|This message contains images. If you don't see images, click here to view.|
Advertise in this news brief.
SCAI Call to Action: Permanent SGR Fix in Sight, and We Need Your Help
You can help persuade Congress to fix the sustainable growth rate once and for all. For more than two decades, physicians have faced an annual across-the-board, double-digit cut in Medicare reimbursement as mandated by a law requiring a sustainable growth rate. Unless Congress intervened, physicians' fees would be cut.
This year is no exception: A 21 percent cut is slated to go into effect April 1. In past years, Congress consistently applied a short-term "patch," negating the cut for the year ahead but never delivering a long-term solution. This year, legislation on deck to be introduced in the next few days would offer a permanent fix to the sustainable growth rate issue. SCAI is urging physicians to take action today in support of this legislation. Follow the link for details on how you can help.
| Share this article:
Love San Diego? Make Sure You Register for SCAI 2015 by Next Week to Save!
Love San Diego? Can't wait to go back? Then don't miss Interventional Cardiology's Annual Meeting: SCAI 2015 in San Diego May 6-9. No other interventional education program matches SCAI's focus on quality in the cath lab, as well as bringing you emerging trends in research and helping you apply it to clinical practice, all in an intimate learning environment of fellow interventionalists and cath lab professionals. Enroll by March 25 and save!
SCAI expresses deep appreciation for the generous educational grant support of the SCAI 2015 Scientific Sessions while taking sole responsibility for all content developed and disseminated through this event.
Platinum supporters: Abbott Vascular; Medtronic
- Silver supporter: AstraZeneca
- Bronze supporters: Cook Medical; Cordis, a Johnson & Johnson Company; Gilead; The Medicines Company, St. Jude Medical
Image of the Week
Sameer Gafoor, MD, reviews the use of a Watchman device in the case of an elderly patient with permanent atrial fibrillation.
Boston Scientific's Watchman Device Ready to Enter US Market
Boston Scientific has finally received Food and Drug Administration approval for its Watchman Heart Device after two failed attempts. The device, which has been in markets outside of U.S. since 2005, has struggled to gain approval after complications stemming from efficacy and complexity during implantation.
Related: Society Testifies in Support of Limited FDA Approval of Watchman Device (SCAI)
It's Not Our Founding Fathers' Cath Lab
At the Society for Cardiovascular Angiography and Interventions' Leadership Boot Camp, catheterization laboratory teams will learn skills they need to thrive while tackling high-pressure, high-stakes challenges.
Blood Clot Removal Boosts Stroke Risk in Heart Attack Patients
Relaxnews via Yahoo News
Thombectomy during treatment for a heart attack has been found to increase the risk of stroke, researchers said.
The study led by McMaster University and the University of Toronto is the largest of its kind to date.
Promising Findings Shown for Heart-related Issues
Positive results supporting the use of minimally invasive heart valve replacement as a potential alternative to surgery, plus evidence a new class of cholesterol-lowering drugs may also reduce the risk of cardiac events were just two of the highlights from the second day of the American College of Cardiology meeting. One of the most highly anticipated studies presented at the 64th annual ACC Scientific Sessions in San Diego were results from the PARTNER 1 trial that looked at outcomes of patients who underwent transcatheter aortic valve replacement who were deemed to be at high risk to have open heart surgery.
Patients Who Experience Most Severe Form of Heart Attack May Benefit From Angioplasty
American College of Cardiology via News-Medical.net
Patients who experience the most severe form of heart attack — ST-segment elevation myocardial infarction — and suffer from substantial narrowing in multiple heart arteries may benefit from receiving angioplasty in constricted arteries not affected by the heart attack, thereby reducing the need for future angioplasty, according to research presented at the American College of Cardiology's 64th Annual Scientific Session.
New Cholesterol-lowering Drug 'Could Halve Risk of Heart Attack, Stroke'
Medical News Today
Currently, statin therapy is the standard treatment for many patients with high cholesterol. But a new study published in The New England Journal of Medicine claims a drug called evolocumab could be much more effective; it reduced cholesterol levels so dramatically that patients' risk of cardiovascular events — such as heart attack and stroke — fell by more than half, compared with those receiving standard therapy alone.
CT Coronary Angiography Can Accurately Diagnose Coronary Artery Disease
American College of Cardiology via News-Medical.net
Use of computed tomography coronary angiography, which provides 3-D images of the heart, coupled with standard care allows doctors to more accurately diagnose coronary artery disease in patients presenting with chest pain, therefore, leading to more appropriate follow-up testing and treatments. Data also showed a trend toward a lower incidence of heart attacks among the group receiving the tests, known as CT scans, compared to usual care.
Younger Women Often Ignore Early Heart Attack Signs
Women between the ages of 30 and 55 tend to ignore early heart attack symptoms, which may be part of the reason more young women die from heart attacks than young men, according to new research by Yale School of Public Health.
Many women delay seeking medical attention when they have a heart attack because they don't realize they are having one at first, said Judith Lichtman, of the Yale School of Public Health.
Patients 80 Years and Older Would Benefit From Aggressive Treatment
American College of Cardiology via Medical Xpress
Patients over age 80 with acute coronary syndromes would likely benefit from more invasive tests and therapies that may otherwise be denied them due to their age, according to research presented at the American College of Cardiology's 64th Annual Scientific Session in San Diego. The study focused on treatment approaches for older patients with non ST-elevation myocardial infarction or the closely related condition unstable angina.
For a complete list of job postings, click here
To post your resume, click here
The news summaries appearing in SCAI This Week are based on original information from news organizations and are produced by Multibriefs, an independent e-mail newsletter publisher. SCAI is not responsible for the content of sites external to SCAI, nor do reports in SCAI This Week constitute the official opinion of SCAI.
The SCAI This Week news roundup is provided as a timely update for SCAI members and other healthcare professionals. Links to articles are provided for readers' convenience and may be of use in discussions with patients or colleagues. Questions and comments about SCAI This Week may be directed to Multibriefs at email@example.com.
Missed last week's issue? See which articles your colleagues read most.
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063